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Abstract
Objective: In order to complete the knowledge of the genomic organization of the human thyroglobulin
gene, the present work was designed to establish the intron±exon organization from exon 24 to exon
35 and to construct a more complete physical map of the gene.
Design: Screening of two genomic libraries, and subsequent restriction mapping, hybridization and
sequencing were used to characterize the recombinant phages.
Methods: Two human genomic DNA libraries were screened by in situ hybridization. Southern blotting
experiments were performed to characterize the phage inserts. The Long PCR method was used to
amplify the genomic DNA region containing exon 24. Intron±exon junction sequences were
determined by using the Taq polymerase-based chain termination method.
Results: We isolated and characterized ®ve l phage clones that include nucleotides 4933 to 6262 of
the thyroglobulin mRNA, encompassing exons 25±35 of the gene. The remaining exon 24
(nucleotides 4817±4932) was sequenced from the ampli®ed fragment. In total, 8010 intronic bases
were analyzed.
Conclusions: The present study shows that the ®ve phages isolated and the ampli®ed fragment include
59.4 kb genomic DNA, covering 1446 nucleotides of exonic sequence distributed over 12 exons, from
exon 24 to exon 35. Using previous studies and our current data, 220 kb of the human thyroglobulin
gene was analyzed, a physical map was constructed, and all exon±intron junctions were sequenced
and correlated with the different domains of the protein. In summary, the thyroglobulin gene
contains 48 exons ranging in size from 63 nucleotides to 1101 nucleotides.
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Introduction
Thyroglobulin (TG), the precursor of the thyroid
hormones tri-iodothyronine (T3) and thyroxine (T4), is
a homodimeric glycoprotein of 660 kDa synthesized
and secreted by the thyroid cells into the follicular
lumen (1, 2). TG functions as the matrix for T3 and T4
synthesis and in the storage of the inactive form of
thyroid hormone and iodine. TG is synthesized as a 12S
molecule, but forms 19S homodimers and even 27S
tetramers. In humans, it is coded for by a large gene
approximately 300 kb long (3), located on chromo-
some 8q24.2±8q24.3 (4±7) at 5.5 cR from the
AFMA053XF1 marker (8). The number of exons has
been estimated to be around 48 (9), each of which is
separated by introns varying in size up to 64 kb (3, 8,
9). The 64 kb intron of the TG gene is an example of a
large intron containing a small gene (10). This small
gene codes for the human Src-like adaptor protein
(hSLAP) and appears to be transcribed in the opposite
direction relative to TG.
TG gene expresion is controlled positively by thyro-
tropin (TSH) through the modulation of the intra-
cellular levels of cyclic adenosine monophosphate
(cAMP) via its receptor (TSHr) located at the basal
membrane of the cell (11, 12). Transcription of the TG
gene is regulated by thyroid-speci®c transcription
factors TTF-1, TTF-2 and Pax-8 (13, 14). It is mediated
by binding to the TG promoter on their consensus
sequences (15±17).
Human TG mRNA is 8.5 kb long (18). The general
organization of the sequence showed a 41-nucleotide
5 0-untranslated segment, followed by a single open
reading frame of 8307 bases and a 3 0-untranslated
ISSN 0804-4643European Journal of Endocrinology (2001) 145 485±496
q 2001 Society of the European Journal of Endocrinology Online version via http://www.eje.org
segment ranging from 101 to 120 bp (18±20). TG
mRNA in human thyroid tissues is very hetero-
geneous because of 15 nucleotide polymorphisms,
10 of which result in amino acid changes (21±23),
11 alternatively spliced transcripts (22±27) and four
polyadenylation cleavage-site variants (20). The
preprotein monomer is composed of a 19-amino-
acid signal peptide followed by a 2749-residue
polypeptide (18). Eighty per cent of the monomer's
primary structure is characterized by the presence of
three types of repetitive units (18, 28). The remaining
20%, constituting the carboxy-terminal domain of the
molecule, is not repetitive and shows striking hom-
ology with acetylcholinesterase (18, 29).
After translation, intensive post-translational
processes take place in the endoplasmic reticulum,
Golgi aparatus, apical membrane and follicular
lumen, and include homodimer assembly, intrachain
disul®de-bond formation, glycosylation, sialylation,
sulfation, phosphorylation, iodination and multimer-
ization (2, 30, 31). Several endoplasmic reticulum
chaperones, such as calnexin, Grp94 and Bip, interact
with TG during its maturation (32, 33) and may serve
to prevent export of improperly folded TG proteins.
This process is known as endoplasmic reticulum
quality control (34).
Once TG has reached the follicular lumen, several
tyrosine residues are iodinated and certain iodinated
tyrosines are coupled to form T3 and T4. Five
hormonogenic acceptor tyrosines have been identi®ed
and localized at positions 5, 1291, 2554, 2568 and
2747 in human TG and several tyrosines localized at
positions 130, 847 and 1448 have been proposed as
donor sites (35). The iodination and coupling reactions
are mediated by thyroperoxidase (TPO) with a source of
hydrogen peroxide. They take place in the follicular
space in contact with the apical surface of thyrocytes
(36). Hydrogen peroxide is generated by a metabolic
pathway involving a ¯avoprotein enzyme. Recently, two
cDNAs, ThOX1 and ThOX2 (37), encoding NADPH
oxidases have been cloned. It was suggested that they
constitute the thyroid hydrogen peroxide-generating
system. ThOX1 and ThOX2 proteins are co-localized
with TPO at the apical membrane.
We previously reported the partial genomic organiz-
ation of the 5 0 and 3 0 regions of the human TG gene (8,
9, 38±40). Using Southern blotting, PCRs and
sequencing analysis, we identi®ed the ®rst 23 (8, 39)
and the last 13 (9) intron±exon junctions in the gene.
In order to complete the knowledge of the genomic
organization of the human TG gene, we report the
establishment of the intron±exon borders of exons 24±
35, including sequence data from splicing signals and
the ¯anking intronic regions. On the basis of these
results, we demonstrated that TG gene coding
sequences are split into 48 exons. A more complete
physical map of the gene was constructed.
Materials and methods
Probe amplification by the reverse
transcriptase/polymerase chain reaction
Eight reverse transcriptase/polymerase chain reaction
(RT-PCR) fragments: PCR 2.2, PCR 3.1, PCR 3.2, PCR
3.3, PCR 4.1, PCR 4.2, PCR 5.1 and PCR 5.2, were
used in the screening of human genomic libraries and
in Southern blot analysis (8, 9, 41). These eight RT-
PCR probes map in the central and 3 0 regions of the TG
mRNA and together encompass nucleotides 3012±
8410 (according to new cDNA numbering (19)). The
DNA sequences of each of the oligonucleotides are
shown in Table 1.
Total RNA was prepared from human thyroid tissue
by the method of Chomczynski and Sacchi (42). Two
micrograms total RNA were ®rst reverse-transcribed
with 200 U Moloney murine leukemia virus RT (Gibco
BRL, Life Technology, Gaithersburg, MD, USA) and 20
U RNase inhibitor (Rnasin, Promega, Madison, WI,
USA) in a 20 ml solution containing a standard reverse
transcription buffer (Gibco BRL), 1 mmol/l of each
dNTP (dATP, dCTP, dTTP and dGTP) and 50 pmol
reverse primer for 1 h at 42 8C. The RT was inactivated
at 95 8C.
The PCR reactions were performed in 100 ml, using
a standard PCR buffer (Gibco BRL) containing the
20 ml RT reaction, 2.5 mmol/l MgCl2, 4% dimethyl-
sulfoxide, 2 U Taq polymerase (Gibco BRL) and 50 pmol




Nucleotide sequence (5 0!3 0)
Reverse primer
Nucleotide sequence (5 0!3 0)
PCR 2.2 CTATCAGAGACGCCGCTTTTCCCC CTAAACGCTCCCTGGTCAGACAACC
PCR 3.1 GCGGACGCTGGGAGTCACAGCTGC CAGGACATGGGACACAGGCC
PCR 3.2 GGCCTGTGTCCCATGTCCTG TGGCTCCTGAGGCTGAGAAC
PCR 3.3 GTTCTCAGCCTCAGGAGCCA GGTCCGCATCGCACCGTCGTTCAC
PCR 4.1 ATCATGGAGTCCAATACCCAGGGGC TTCCGACCCTGCAGACTATGTGTG
PCR 4.2 CACACATAGTCTGCAGGGTCGGAA CCCCGCCAAATCCTCGGATGTGGG
PCR 5.1 GTTTGTATCTCAATGTGTTCATCC GCCTTTGCTCTGTTGATGAG
PCR 5.2 CTCATCAACAGAGCAAAGGC CACCGCATGTAGATACTTTATTGA
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of each reverse and forward primers. No dNTP was
added in the PCR reaction, so, as the RT reaction is
diluted 1/5, the ®nal concentration of the nucleotides
was 200 mmol/l. The samples were subjected to 40
cycles of ampli®cation. Each cycle consisted of de-
naturation at 95 8C for 30 s, primer annealing at 55 8C
for 30 s, and primer extension at 72 8C for 1 min. After
the last cycle, the samples were incubated for an
additional 5 min at 72 8C to ensure that the ®nal
extension step was complete. The ampli®ed products
(PCR 2.2, 1076 bp; PCR 3.1, 681 bp; PCR 3.2,
683 bp; PCR 3.3, 884 bp; PCR 4.1, 722 bp; PCR 4.2,
638 bp; PCR 5.1, 724 bp; PCR 5.2, 865 bp) were
analyzed in a 1.5% agarose gel.
Screening of human genomic libraries
Aliquots of human genomic libraries constructed with
l Dash II (Stratagene, La Jolla, CA, USA) or l charon
4 A (kindly provided by Dr T Maniatis, California
Institute of Technology) recombinant phages were used
to infect Escherichia coli XL1-Blue MRA, or Y1090
respectively. Infected bacteria were plated on Petri
dishes and screened by the replica ®lter method
using PCR 2.2, PCR 3.1, PCR 3.2, PCR 3.3, PCR 4.1,
PCR 4.2, PCR 5.1 and PCR 5.2 as hybridization
probes.
Prehybridization and hybridization were carried out
at 42 8C in 50% formamide, 5 Denhardt's solution,
5 SSPE (1 SSPE is 0.15 M NaCl, 0.01 M NaH2PO4
(pH 7.7), and 0.001 M EDTA), 0.5% SDS and 100 mg/ml
sonicated denatured salmon-sperm DNA.
The probes were labeled with [a-32P]dATP by
random priming (Gibco BRL). Filters were washed
with 2 SSC (1 SSC is 0.15 M NaCl and 0.015 M
sodium citrate, pH 7.0), 0.1% SDS, followed by 1 SSC,
0.1% SDS and, ®nally, 0.1 SSC, 0.1% SDS, twice each
at 65 8C. The ®lters were exposed to X-ray ®lm at
270 8C, with an intensifying screen.
Preparation of l phage DNA
Bacteriophage DNA was prepared with the Wizard
lambda preps DNA puri®cation system (Promega). After
elution from the mini column, DNA was extracted twice
with phenol±chloroform, the salt concentration was
adjusted to 2 mol/l with amonium acetate, and the
DNA was precipitated with ethanol.
Southern blot analysis
Restriction and blotting experiments were carried out
using standard procedures (43±45). One microgram l
phage DNA was digested with 10 U EcoRI endonuclease
(Gibco BRL). Prehybridization, hybridization and wash-
ing of the ®lters were performed as described for the
screening of genomic libraries, except that washing was
performed using 0.5% SDS.
In order to map the recombinant clones, the
membranes were hybridized with the same probes
used for the screening of genomic libraries, in separate
experiments. Recombinant phage DNAs were also used
as probes to check the possibility of overlap of
contiguous phages.
Long PCR
The Long PCR technique is suitable for the ampli®ca-
tion of long DNA templates. This approach was used to
amplify the region containing exon 23/intron 23/exon
24/intron 24/exon 25 by primers situated in exons 23
and 25.
In addition, introns 11 and 18 were ampli®ed by
Long PCR with primers located in intron 11±exon 12
and exons 18±19 respectively. The DNA sequences of
each forward and reverse oligonucleotide used for Long
PCR were as previously described (9) except for the
primers located in intron 11 (5 0-gagtgagtccatctgtgtt-
3 0), exon 23 (5 0-AGAATCAAAGGTGATCTTCGACGCC-
3 0) and exon 25 (shown in Table 2).
Long PCR was performed in 50 ml, using a standard
elongase buffer (Gibco BRL) containing 100 ng DNA,
1.3 mmol/l MgCl2, 200 mmol/l of each dNTP, 1 ml
elongase enzyme mix (Gibco BRL) and 10 pmol each of
the forward and reverse primers.
The samples were subjected to 35 cycles of ampli®ca-
tion; each cycle consisted of denaturation at 94 8C for
30 s, primer anealing at 60 8C for 30 s, and primer
extension at 68 8C for 15 min.
The ampli®ed fragments were analyzed in a 1%
agarose gel.
DNA sequencing
The exon and intron±exon-junction sequences were
determined by the Taq polymerase-based chain termin-
ation method ( fmol; Promega) from l phage clone
DNA. Primers were specially designed for each intron±
exon junction. Oligonucleotide sequences and the
positions of their 5 0 ends are shown in Table 2.
Exon±intron borders were characterized by alignment
between the cDNA (19) and genomic sequences, using
the pc gene computer program (Intelligenetics, Inc.,
Geneva, Switzerland).
Results
Approximately 3:4  106 phages from human genomic
libraries were screened by ®lter hybridization with eight
human Tg cDNA probes (PCR 2.2, PCR 3.1, PCR 3.2,
PCR 3.3, PCR 4.1, PCR 4.2, PCR 5.1 and PCR 5.2)
corresponding to 5.4 kb Tg mRNA. One hundred and
thirty-three plaques scored positive and four of them
were randomly selected and puri®ed to homogeneity.
The DNA was prepared from the corresponding phages
and digested with EcoRI. Four different restriction
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patterns were obtained, leading to the identi®cation of
four recombinant phages termed l dash 12, l dash 54,
l dash 72 and l ch 2. Southern blot experiments with
the same probes described for the screening of genomic
libraries were used to localize the phage inserts with
respect to the mRNA sequence, and to determine their
relative orientation. Figure 1 shows the localization of l
dash 12, l dash 54, l dash 72 and l ch 2 clones
according to their positive hybridization fragments.
Clone l dash 72 is located 5 0 to l dash 12, since the
exonic fragments of l dash 72 hybridized with cDNA
probes PCR 3.2 and PCR 3.3 and did not hybridize
with PCR 4.1; the l dash 12 exonic fragments,
however, hybridized with PCR 3.3 and PCR 4.1 and
Figure 1 Relative positions and hybridization patterns of the l phages used in this study. The EcoRI (E) fragments scoring positive for
hybridization are shown, drawn to scale in the 5 0-to-3 0 direction. The lower bars represent the hybridization patterns with cDNA
speci®c probes obtained by RT-PCR. The positions of the ®rst and last nucleotides of each probe are shown in parentheses.
Table 2 Oligonucleotides used as primers in sequence reactions. Exon sequences are in capital letters and introns sequences are in bold
lower-case letters. The positions of exonic primers are indicated according to cDNA numbering. The positions of intronic primers are
indicated from the beginning of the closed exon. Primers located upstream have negative numbering, while those located downstream
have positive numbering.
Forward primer Reverse primer
Exon no.
Position of
5 0 end Nucleotide sequence (5 0!3 0)
Position of
5 0 end Nucleotide sequence (5 0!3 0)
24 4817 ATTGCACAGAGGACGAGGCC 4932 CTGGTCAGAAGTCATGCAGGC
25 4933 AAACGAGATGCACTGGGG 5027 ACAGCTGGAGAATCTTGACCATGGC
26 5049 ATCCACCACAACACTTCAGAAACGC 5146 TGGCTCCTGAGGCTGAGAAC
27 5239 ATCATCTGTGGGTTGCTGAGC 5397 GATGAACTCCTGGTCTCCAAGACGC
28 251 tacccagtgacagcacactcaagc 5463 CCAGAGATAAACCTGCTGAAAATTGG
29 5468 ATTCTGACATGGGGTCTCGGCC 5547 TGCTTCTGTTGGAGATGCTGG
30 5552 TGACAACAGAACTTTTCTCC 5686 acGAGAAAGGCACCATAGG
5640 CAAGCACCTGTTTTCAGCCC 214 agggagtcaacttcctgcacc




31 5691 TGTGCAGGAGCACTCTTTCT 5789 TCATCACACACCTGTGCCTCT
2996 gtgtcataactcatggatcactgtgg
32 5882 TGAAGAACTTTTACACTCGCCTGCCG +27 gtgagacacaagtagcttaccc
33 5981 TTGAATGTGAACGACGGTGCGATGCG +49 aactgcagagtactgtgcg
34 6056 GAGGAGAGGTGACATGTCTCAC 6199 TGGGCTTCTGGTACCATCCG
35 265 gccttctgaactcgatgatacc 6262 CTTTCTCTGTGAGGGAAGGC
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did not hybridize with PCR 3.2. Clone l dash 54 was
tentatively located in the same region of l dash 72, on
the basis that both phages contained the same 2.8 kb
exonic fragment hybridizing only to PCR 3.3. Cross-
hybridization analysis showed an overlap of approxi-
mately 5.3 kb between l dash 72 and l dash 54.
We previously reported the identi®cation of the
intron 30/exon 30/intron 31 junction sequences in
the clone named l dash 171 (46), obtained in the
same initial screening of the present study. As shown
in Fig. 1, l dash 12 and l dash 171 displayed three
exonic fragments with similar hybridization patterns.
The presence in l ch 2 of a fragment of 9.5 kb which
was negative for PCR 3.3 and positive for PCR 4.1
allowed localization of the l ch 2 3 0 relative to l dash
12.
The possible overlap between the pairs l dash 54/l
dash 171, l dash 171/l dash 12 and l dash 12/l ch 2
was con®rmed by cross-hybridization using each phage
as probe. Altogether, the ®ve phages contain 52.1 kb
contiguous genomic DNA.
In order to identify the intron±exon boundaries of
the TG gene and to analyze the regions responsible for
pre-mRNA proccessing, we performed cycle sequencing
reactions from primers designed according to a
sequencing strategy (i.e., the establishment of one
intron±exon junction allowed us to design the follow-
ing primer to sequence the neighbouring intron±exon
border and so on). The intron±exon junctions and
splicing sites were sequenced from exonic and intronic
primers (Table 2). Our sequencing results show that
l dash 72 contains exons 25±27, l dash 54 exon 27, l
dash 171 exons 28±32, l dash 12 exons 29±34 and
l ch 2 exon 35. The DNA sequences surrounding the
intron±exon junctions are shown in Fig. 2.
Unfortunately, the characterization of recombinant
phages showed that the exon 24 was not included in
the positive phages obtained in the initial screening.
Consequently, the genomic DNA fragment between
exons 23 and 25 was generated by Long PCR. The
7.2 kb ampli®ed fragment was sequenced with exonic
primers and the intron 23±exon 24±intron 24
junctions were determined (Fig. 2).
The ®ve phages and the ampli®ed fragment included
59.4 kb genomic DNA covering 1446 nucleotides of
exonic sequence (from nucleotides 4817 to 6262 of the
mRNA, according to the new cDNA numbering system
(19)) distributed in 12 exons, from exon 24 to 35,
whose sizes range between 63 and 192 nucleotides
(Table 3). The number of nucleotides of intronic
sequence obtained was 8010 (Fig. 2).
We established a general picture of the complete gene
by integrating EcoRI restriction, hybridization, Long
PCRs and sequence experiments from previous studies
(8, 9, 38±40) with our present data (Fig. 3). Twenty-
nine different recombinant phage clones were isolated
and characterized. In total, 220 kb of the TG gene were
analyzed. These results demonstrated that the number
of exons in the human TG gene is de®nitely 48, the
exon size ranging between 63 and 1101 nucleotides
(Table 3). We previously reported two intronic gaps in
introns 11 and 18 (8); these were ampli®ed by Long
PCR in the present study. Another gap in intron 40 was
considered (9), since the cross-hybridization between l
dash 31 and l dash 56 revealed the existence of an
intronic overlapping region of approximately 1 kb,
indicating that the complete intron 40 had been
cloned. However, there are still three intronic gaps in
introns 35, 41 and 43. Our restriction analysis showed
that intron 35 contains more than 11 kb. Intron 41
corresponds to large (64 kb) intron containing the
human Src-like adaptor protein gene (10); the size of
intron 43 has been determined by van Ommen et al. as
17 kb (47). Donor and acceptor splicing-site sequences
of the 48 exons are shown in Table 3. When we
compared our data with general splicing consensus
sequences (48), we found that the GT±AG rule is
maintained in all introns.
Discussion
In addition to the ®rst 23 and the last 13 exons intron±
exon boundaries available from our previous studies,
we now report the sequencing and characterization
of the intron±exon organization of exons 24±35 of
the human TG gene. All exon borders and intron±
exon junctions were localized precisely and also
sequenced (Table 3). A more complete EcoRI restriction
map of the human TG gene was constructed, and the
relative positions of the 48 exons was established
(Fig. 3).
Knowledge of the structural organization of the
human TG gene will help to elucidate the func-
tions of the different domains of the protein. The
highly organized internal protein structure of the TG
includes cysteine-rich repetitive units (8, 18, 28),
hormonogenic sites (18, 49) and receptor-binding
domains (50±54).
We analyzed the relationship between the three
families of cysteine-rich repetitive units (8, 18, 28) and
the intron±exon junction organization (Fig. 4). The
monomer contains 11 type-1, 3 type-2 and 5 type-3
repeat motifs.
Detailed analysis of the repeats shows the following
distribution. (i) Type-1 -2, -4, -7, -10 and -11 repeats
are each encoded by a single exon (exons 4, 8, 10, 16
and 22 respectively), repeats 1 and 9 are each encoded
by two exons (exons 2 and 3, and 14 and 15
respectively), repeats 3 and 8 are each encoded by
three exons (exons 5, 6 and 7, and exons 11, 12 and
13 respectively), and repeats 5 and 6 are a fraction of
exon 9. (ii) The three type-2 repetitive elements map
between exons 20 and 21. (iii) The type-3 domain
includes two subtypes, 3a and 3b, and maps between
exons 23 and 37 (3a-1, between exons 23 and 26; 3b-1,
between exons 26 and 30; 3a-2, between exons 30 and
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Figure 2 Sequence data for intron±exon boundaries 24±35 and their ¯anking intronic regions. The ®rst and last 10 nucleotides of
each exon are indicated by capital letters; their ¯anking intronic sequences are indicated by lower-case letters. Numbers indicate the
®rst and last nucleotides of each exon. The gaps (¼¼) represent intron regions whose sequences were not determined.
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Figure 2 continued
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33; 3b-2, between exons 33 and 36; and 3a-3,
between exons 36 and 37). Type-1 repeats could
function as binders and reversible inhibitors of the
protease in the lysosomal pathway (28).
The ®ve hormonogenic acceptor sites (8, 18, 49)
are located at positions 5, 1291, 2554, 2568 and
2747 of the Tg monomer within exons 2, 18, 44, 45
and 48 respectively (Fig. 4), while three potential
outer ring donors were identi®ed at tyrosine residues
130, 847 and 1488 (35), which correspond to exons
4, 10 and 21 (Fig. 4). Tyrosine 5 is the most likely
acceptor site for the donated iodotyrosyl from pos-
itions 130 (49).
On the other hand, TG interacts with several proteins
during their intracellular transport to the surface of the
cell, or with components of the apical membrane in the
Table 3 Intron±exon organization of the TG gene. Exons sequences are in capital letters, intron sequences are in lower-case letters.
Intron class indicates which nucleotide in the codon is split by the intron. The consensus sequences of Shapiro and Senaphaty (48) are
indicated at the bottom.
3 0-end intronic
sequences Exon 5 0 end Exon no.
Exon size
(bp) Exon 3 0 end
5 0-end intronic
sequences
5 0 flanking region 5 0 untranslated segment 1 108 ATC TTC G gtaagttctg
acttttcttttcctag AG TAC CAG 2 109 AGC TTC CA gtaaggctta
ctgtgtctcctcctag G ACT GTC 3 98 GTG GCT T gtaagtggga
ctccttgtacccacag GT CTG TCA 4 204 AAG CGA T gtagtttcac
ttgtgaaaatgtttag GT CCA AGG 5 160 TAC AAC AG gtaaggggag
tctcattctctccaag G TTT CCA 6 107 GAG ACA G gtgagtgata
tgctgtctttgctcag GT TTG GAG 7 144 TTC CGA T gtaagtaata
tgtggatttcctctag GC CCC ACA 8 186 TCT TGT G gtgggtttcc
actttgtctcatgcag CT GAA GGC 9 1101 AAG AAA T gtaagtctgt
cattgttcctccccag GC CCC ACG 10 585 CCA ACA T gtgagctaac
agttttattcccctag GT CCT GGC 11 240 CAG TCT A gtagtggtgc
ccttccctgactccag CC TTA AGC 12 138 GGG ACT G gtaaggaggg
cttggctcttttccag GG CAC TGC 13 78 CCA CAG T gtaagcgaag
cctctctctcccacag GC CCG ACA 14 113 TGC CTA GAA gtaagggtct
cccggctttgtctcag ACA GGA GAG 15 103 GCC CAG T gtgagtagca
cttgtctctgtgtcag GC CCA AGC 16 201 TGT GAG A gtaagtcatg
actttccttctcccag GC CCG CGG 17 213 TGC CAA C gtgagtggca
tggtgcttgcctgcag GG CCC CAG 18 155 CAG ATC CAG gtacatgcct
gtctgtcttcttgtag GTG AAG ACT 19 157 GAC ATT G gtatgttttt
atcctgtgtcttacag AG AGA GCC 20 219 GGA TGC G gtaggtccac
ctctgtttttttctag TT AAG TGT 21 150 ACT CAC T gtaagttctg
aatctattggttctag GT GTC ACT 22 171 TGT TTG A gtaggtgctg
tctgctttatttttag TG ATG CAG 23 117 TTG ACA G gtgaggagtg
cccatggtgcttgcag AT TGC ACA 24 116 TCT GAC CAG gtgaggtggg
atctttccatctccag AAA CGA GAT 25 109 AAA AAG G gtaggttggt
ttctgcctttccccag GC CAA GGA 26 192 CAA GGA G gtaatgttgg
ctcttgcgattctcag GT GCC ATC 27 168 ATC AAG A gtaagtcttt
acatcttcctttgcag GT CTG ACA 28 66 TGG AAA G gtgagctccg
ttttttttcctcctag AT TCT GAC 29 81 GAA GCA G gtactgaccc
cctgcttctttttcag GT TTG ACA 30 138 CTT TCT C gtaagtatcc
actctcttgcctgtag GT TGT GTG 31 177 AAG AAA G gtgagcactt
ttcttcctctatgaag TT ATA CTG 32 112 TCT AAT GG gtaagctact
tctcttcctatgccag G TTC TTT 33 80 TTA AAA G gtaataatgg
tttttttccaccccag GA GGA GAG 34 144 AAG CCC A gtaagtaccc
gctttttccttttcag TT GCT CAA 35 63 GAG AAA G gtaagttcat
ttgccttctctcctag TG TCT CTG 36 135 TTG TCG G gtaaggggag
tccctcttttctgcag AA TGT TCC 37 165 AAG CCA G gtaagcccaa
tttctccttccaacag GA ATC TCT 38 220 AAG CCA AG gtatgggttg
cagtctgtatctgcag G GCC AGC 39 94 CAG AAT GTG gtgagttcaa
tctccaatacccacag GCC CCT AAC 40 160 AGT TCT G gtgagttgct
ttcctcttttctgaag GG TCC GGA 41 203 GTG CTG ATG gtaagtggtg
ctgctttctcttccag GGA GGC TCC 42 165 CAG ACC AAG gtgagcactt
gttgcatccaatgcag CTC TTG GCC 43 168 GCT GTG AAG gtaagcaggg
ctttttttttttctag CAA TTT GAG 44 182 GCC ACC CG gtaagctaag
gttctcttttcaccag G GAC TAC 45 108 CAT GGC AG gtaagacgct
tcctctgttttctcag C CTG GAG 46 135 AGA TCA GG gtaattttgg
cttctcatttgcccag A AAT CCC 47 191 TCT GCA G gtagcaaagc
tgcccctctgtttcag AT GGA GCC 48 222 3 0 untranslated segment 3 0 flanking region
....ttttttttttncag G........ Consensus sequences ........AG gtaagt.....
cc cccccc g
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exocytosis and endocytosis pathways of thyrocytes,
such as the apical membrane asialoglycoprotein
receptor (ASGPR) (50), megalin (51, 52) and protein
disul®de isomerase (PDI) (53, 54). The ASGPR
transports newly synthesized TG to the follicular
lumen. It is hypothesized that the ASGPR is also
indirectly involved in the endocytosis and proteolytic
cleavage of highly iodinated TG by binding and
sequestering immature TG. The region of TG that
interacts with the receptor is unknown. It has recently
been shown that the TG regulation of thyroid gene
expression is mediated by the ASGPR (50). It is
interesting to note that the follicular TG acts as a
feedback suppressor of thyroid function, by suppressing
the expression of TTF-1, TTF-2 and Pax-8 and,
consequently, reducing the expression of the TG, TPO,
sodium/iodide symporter (NIS) and TSHr genes. These
®ndings support the idea that TG is not only the
substrate for the biosynthesis of the thyroid hormones
but also a regulator of thyroid function, playing a role
in transcriptional signaling or being involved in some
unknown mechanisms that remain to be determined.
Figure 3 Schematic representation of the the physical EcoRI restriction map of the human TG gene and the distribution of these 48
exons. The exons are indicated by vertical black boxes and the introns are indicated by continuous lines. The gene is drawn to scale
in the 5 0-to-3 0 direction. EcoRI (E) restriction sites are shown. The dotted line denotes the segment of introns not included in our
phages.
Figure 4 Exon organization and correlation with repetitive and hormonogenic domains. The exons are indicated by white boxes and
the repetitive units by shaded boxes. Tyrosine residues, involved as acceptor (TYR) and donor (tyr) sites in thyroid-hormone
synthesis, are shown.
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Highly iodinated TG is removed from the follicular
lumen by internalization via pseudopod ingestion and
micropinocytosis, followed by fusion of the endosome
with a lysosome and its proteolytic cleavage. It has
recently been reported that megalin, a member of the
low-density-lipoprotein receptor family, participates in
the internalization of mature TG as a high-af®nity
receptor for TG (51). Megalin interacts with a heparin-
binding region (SRRLKRP) in the carboxyl-terminal
portion of rat TG (51). However, this domain was not
detected when we searched the complete human TG
protein for heparin-binding consensus sequences, using
the pc gene computer program (Intelligenetics, Inc.).
Megalin plays a role in intact TG transcytosis from the
apical surface to the basolateral surface of the thyrocyte
(52). Subsequently, the endocytosis for proteolytic
cleavage in the lysosomal pathway occurs via other
mechanisms such as ¯uid-phase uptake or uptake by
other af®nity receptors.
In addition, it has been suggested that there is, at
the apical surface of the thyroid cell, a quality
control mechanism that prevents premature lyso-
somal transfer and degradation of immature TG
(53). The immature molecules are internalized and
recycled through the trans-Golgi compartments. PDI
is thought to be a candidate for the receptor that
mediates the internalization (54). The domain of
TG responsible for the binding to the membrane is
located between exons 10 (Ser789) and 16 (Met1173).
This region contains a stretch of 385 amino acid
residues that includes the cysteine-rich type I-7, I-8,
I-9 and I-10 motifs and two N-linked glycan moieties.
Cleavage of the glycan moieties reduces the binding
af®nity, suggesting that these complex-type oligo-
sacharide units are involved in the interaction
between this domain and PDI.
During the completion of the present study and
after our sequences had appeared in GenBank, the
International Human Genome Project reported a
draft of chromosome 8 that included the TG gene
(http://www.ncbi.nlm.nih.gov/genome/guide/human).
As expected, a comparison of the genomic sequences
from both sources, performed using the blast version
2.1 computer program (National Center for Bio-
technology Information, http://www.ncbi.nlm.nih.gov/
BLAST/index.compat.html), revealed perfect sequence
homology and some nucleotide differences that could
be due to single nucleotide polymorphisms (SNPs).
In summary, on the basis of the previous studies and
our present data, a physical map of the human TG gene
was constructed and all intron±exon junctions were
sequenced and correlated with the different domains of
the protein. The TG gene was found to contain 48
exons, the exon sizes ranging between 63 and 1101
nucleotides.
The identi®cation of the complete genomic
organization of the human TG gene is of potential
interest in terms of our undertanding of the
structure±function relationship. It also opens up
new perspectives in the study of the pathogenesis of
hereditary thyroid diseases involving defective TG
synthesis, facilitating the rapid detection of new
mutations in the TG gene.
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